Membrane microdomains: Role of ceramides in the maintenance of their structure and functions

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 3, 2009, Pages 666-675

  Staneva, Galya ^a   Momchilova, Albena ^a   Wolf, Claude ^b   Quinn, Peter J ^c   Koumanov, Kamen ^a  

^a INSTITUTE OF BIOPHYSICS AND BIOMEDICAL ENGINEERING   (Bulgaria)

^b HÔPITAL SAINT ANTOINE   (France)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Ceramide; Cholesterol; GUV; Lipid signaling pathway; Phospholipase A2; Raft; Sphingomyelin; Sphingomyelinase

Indexed keywords

CERAMIDE; CHOLESTEROL; GLYCEROPHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ARTICLE; BILAYER MEMBRANE; CELL MEMBRANE; CHEMICAL STRUCTURE; ENZYME ACTIVITY; GEL; MEMBRANE STRUCTURE; MEMBRANE VESICLE; MISCIBILITY; MOLECULAR INTERACTION; PHASE TRANSITION; PRIORITY JOURNAL;

4-CHLORO-7-NITROBENZOFURAZAN; CERAMIDES; CHOLESTEROL; MEMBRANE MICRODOMAINS; MICROSCOPY, FLUORESCENCE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A2; SPHINGOMYELIN PHOSPHODIESTERASE; UNILAMELLAR LIPOSOMES;

EID: 60549102443     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.10.026     Document Type: Article

References (55)

1. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science 274 (1996) 1855-1859
2. Manes S., and Viola A. Lipid rafts in lymphocyte activation and migration (review). Mol. Membr. Biol. 23 (2006) 59-69
3. Hancock J.F. Lipid rafts: contentious only from simplistic standpoints. Nat. Rev. Mol. Cell Biol. 7 (2006) 456-462
4. Morales A., Lee H., Goni F.M., Kolesnick R., and Fernandez-Checa J.C. Sphingolipids and cell death. Apoptosis 12 (2007) 923-939
5. Chiantia S., Kahya N., Ries H., and Schwille P. Effects of ceramide on liquid-ordered domains investigated by simultaneous AFM and FCS. Biophys. J. 90 (2006) 4500-4508
6. Johnston I., and Johnston L. Ceramide promotes restructuring of model raft membranes. Langmuir (2006) 11284-11289
7. Laviad E.L., Albee L., Pankova-Kholmyansky I., Epstein S., Park H., Merril A.H., and Futerman A.H. Characterization of ceramide synthase 2 - tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J. Biol. Chem. 283 (2008) 5677-5684
8. Levade T., and Jaffrezou J.P. Signalling sphingomyelinases: which, where. how and why?. Biochim. Biophys. Acta 1438 (1999) 1-17
9. Veldman R.J., Maestre N., Aduib O.M., Medin J.A., Salvayre R., and Levade T. A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem. J. 355 (2001) 859-868
10. Liu P.S., and Anderson R.G.W. Compartmentalized production of ceramide at the cell-surface. J. Biol. Chem. 270 (1995) 27179-27185
11. Cremesti A., Paris F., Grassme H., Holler N., Tschopp J., Fuks Z., Gulbins E., and Kolesnick R. Ceramide enables Fas to cap and kill. J. Biol. Chem. 276 (2001) 23954-23961
12. London M., and London E. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for raft structure and function. J. Biol. Chem. 279 (2004) 9997-10004
13. Veiga M.P., Arrondo J.L., Goni F.M., and Alonso A. Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. Biophys. J. 76 (1999) 342-350
14. Kolesnick R.N., Goni F.M., and Alonso A. Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell. Physiol. 184 (2000) 285-300
15. Hartel S., Fanani M.L., and Maggio B. Shape transitions and lattice structuring of ceramide-enriched domains generated by sphingomyelinase in lipid monolayers. Biophys. J. 88 (2005) 287-304
16. G. Staneva, C. Chachaty, C. Wolf, K. Koumanov, P. J. Quinn, The role of sphingomyelin in regulating phase coexistence in complex lipid model membranes: competition between ceramide and cholesterol, Biochim. Biophys. Acta 1778 (2008) 2727-2739.
17. Massey J.B. Interaction of ceramides with phosphatidylcholine, sphyngomyelin and sphyngomyelin/cholesterol bilayers. Biochem. Biophys. Acta 1510 (2001) 167-184
18. Helvoort A., and van Meer G. Intracellular lipid heterogeneity caused by topology of synthesis and specificity in transport. Example: sphingolipids. FEBS Lett. 369 (1995) 18-21
19. Lopez-Montero I., Rodriguez N., Cribier S., Pohl A., Velez M., and Devaux P. Rapid transbilayer movement of ceramides in phospholipid vesicles and in human erythrocites. J. Biol. Chem. 280 (2005) 25811-25819
20. Bai J., and Pagano R.E. Measurement of spontaneous transfer and transbilayer movement of BODIPY-labeled lipids in lipid vesicles. Biochemistry 36 (1997) 8840-8848
21. Contreras F.-X., Villar A.-V., Alonso A., Kolesnick R.N., and Goni F.M. Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J. Biol. Chem. 278 (2003) 37169-37174
22. Koumanov K.S., Momchilova A.B., Quinn P.J., and Wolf C. Ceramides increase the activity of the secretory phospholipase A2 and alter its fatty acid specificity. Biochem. J. 363 (2002) 45-51
23. Angelova M., and Dimitrov D. Liposome electroformation. Faraday Discuss. Chem. Soc. 81 (1986) 303-311
24. Staneva G., Angelova M.I., and Koumanov K. Phospholipase A2 promotes raft budding and fission from giant liposomes. Chem. Phys. Lipids 129 (2004) 53-62
25. Veatch S.L., Polozov I.V., Gawrisch K., and Keller S.L. Liquid domains in vesicles investigated by NMR and fluorescence. Biophys J. 86 (2004) 1922-2910
26. Weis R.M., and McConnell H.M. Cholesterol stabilizes the crystal-liquid interface in phospholipid monolayers. J. Phys. Chem. 89 (1985) 4453-4459
27. Ruano M., Nag K., Worthman L., Casals C., Perez-Gil J., and Keough K. Differential partitioning of pulmonary surfactant protein SP-A into regions of monolayers of dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylcholine/dipalmitoylphosphatidylglycerol. Biophys. J. 74 (1998) 1101-1109
28. Dietrich C., Bagatolli L.A., Volovyk Z.N., Tompson N.L., Levi M., Jacobson K., and Gratton E. Lipid rafts reconstituted in model membranes. Biophys. J. 80 (2001) 1417-1428
29. Baumgart T., Hess S.T., and Webb W.W. Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension. Nature 425 (2003) 821-824
30. Bacia K., Schwille P., and Kurzchalia T. Sterol structure determines the separation of phases and the cuvature of the liquid-ordered phase in model membranes. Proc. Natl. Acad. Sci. 102 (2005) 3272-3277
31. Gulbins E., and Kolesnick R. Acid sphingomyelinase-derived ceramide signaling in apoptosis. Subcell. Biochem. 36 (2002) 229-244
32. Taniguchi Y., Ohba T., Miyata H., and Ohki K. Rapid phase change of lipid microdomains in giant vesicles induced by conversion of sphingomyelin to ceramide. Biochim. Biophys. Acta 1758 (2006) 145-153
33. Holopainen J.M., Angelova M., and Kinnunen P.K.J. Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys. J. 78 (2000) 830-838
34. Wick R., Angelova M.I., Walde P., and Luisi P.L. Microinjection into giant vesicles and light microscopy investigation of enzyme-mediated vesicle transformations. Chem. Biol. 3 (1996) 105-111
35. Sanchez S.A., Bagatolli L.A., Gratton E., and Hazlett T.L. A two-photon view of an enzyme at work: Crotalus atrox venom PLA2. Interaction with single-lipid and mixed-lipid giant unilamellar vesicles. Biophys. J. 82 (2002) 2232-2243
36. Koumanov K.S., Quinn P.J., Bereziat G., and Wolf C. Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2. Biochem. J. 336 (1998) 625-630
37. Veatch S.L., and Keller S.L. Separation of liquid phases in giant vesicles of ternary mixtures of phospholipids and cholesterol. Biophys. J. 85 (2003) 3074-3083
38. McConnel H.M. Harmonic shape transitions in lipid monolayer domains. J. Phys. Chem. 94 (1990) 4728-4731
39. Lee K.Y.C., and McConnell H.M. Quantized symmetry of liquid monolayer domains. J. Phys. Chem. 97 (1993) 9532-9539
40. Holopainen J.M., Brockman H.L., Brown R.E., and Kinnunen P.K.J. Interfacial interactions of ceramide with dimyristoylphosphatidylcholine: impact of the N-acyl chain. Biophys. J. 80 (2001) 765-775
41. Sot J., Bagatolli L.A., Goni F.M., and Alonso A. Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers. Biophys. J. 90 (2006) 903-914
42. Fidorra M., Duelund L., Leidy C., Simonsen A.C., and Bagatolli L.A. Absence of fluid-ordered/fluid-disordered phase coexistence in ceramide/POPC mixtures containing cholesterol. Biophys. J. 90 (2006) 4437-4451
43. Fanani M.L., Hartel S., Oliveira R., and Maggio B. Bidirectional control of sphingomyelinase activity and surface topography in lipid monolayers. Biophys. J. 83 (2002) 3416-3424
44. Sot J., Ibarguren M., Busto J.V., Montes L.-R., Goni F.M., and Alonso A. Cholesterol displacement by ceramide in sphingomyelin-containing liquid-ordered domains, and generation of gel regions in giant lipidic vesicles. FEBS Lett. 532 (2008) 3230-3236
45. Johnston I., and Johnston L. Sphingomyelinase generation of ceramide promotes clustering of nanoscale domains in supported bilayer membranes. Biochim. Biophys. Acta 1778 (2008) 185-197
46. Huang J.W., Goldberg E.M., and Zidovetzki R. Ceramide reduces structural defects in phosphatidylcholine bilayers and activates phospholipase A2. Biochem. Biophys. Res. Commun. 220 (1996) 834-838
47. Holopainen J.M., Lehtonen J.Y.A., and Kinnunen P.K.J. Lipid microdomains in dimyristoylphosphatidylcholine/ceramide liposomes. Chem. Phys. Lipids 88 (1997) 1-13
48. Holopainen J.M., Subramanian M., and Kinnunen P.K.J. Sphingomyelinase induces lipid microdomains formation in fluid phosphatidylcholine/sphingomyelin membrane. Biochemistry 37 (1998) 17562-17570
49. Needham D., and Nunn R.S. Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophys. J. 58 (1990) 997-1009
50. Zhelev D.V. Material property characteristics for lipid bilayers containing lysolipid. Biophys. J. 75 (1998) 321-330
51. Grandbois M., Clausen-Schaumann H., and Gaub H. Atomic force microscope imaging of phospholipid bilayer degradation by phospholipase A2. Biophys. J. 74 (1998) 2398-2404
52. Koumanov K., Wolf C., and Bereziat G. Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI. Biochem. J. 326 (1997) 227-233
53. Klapisz E., Masliah J., Bereziat G., Wolf C., and Koumanov K.S. Sphingolipids and cholesterol modulate membrane susceptibility to cytosolic phospholipase A2. J. Lipid Res. 41 (2000) 1680-1688
54. Brown W.J., Chambers K., and Doody K.A. Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function. Traffic 4 (2003) 214-221
55. Y. Zhang, X. Li, K.A. Becker, E. Gulbins, Ceramide-enriched membrane domains-Structure and function, Biochim. Biophys. Acta, doi:10.1016/j.bbamem.2008.07.030.